Regulatory Affairs & Intellectual Property Rights

Regulatory Affairs has a very specific meaning within the healthcare industries . It's regulations are for systematic manufacturing and marketing of safe, efficacious and qualitative drugs. Improving  new regulations and adopting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation .

The market is expected to expand at a substantial 11.5% CAGR from 2015 to 2023 and rise to a valuation of US$5.7 billion by 2023.

  • Regulatory Affairs Filing and Documentation
  • Enhancing Regulatory Science for Public Health
  • Meeting the Challenges for Regulating
  • Patent and types of Patent Application
  • Copyrights
  • Trademark
  • Infringement
  • Iprs and Market for Technology
  • Role of Patent Co-operation Therapy

Related Conference of Regulatory Affairs & Intellectual Property Rights

August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
August 29-30, 2018 |

International Conference and Exhibition on Drug Safety & Pharmacovigilance

Park Inn By Radisson, Toronto, Canada
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 14-15, 2018

13th International Conference on Biosimilars and Biologics

Lisbon, Portugal
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Regulatory Affairs & Intellectual Property Rights Conference Speakers

Recommended Sessions

Related Journals

Are you interested in